Roivant Sciences Ltd. (ROIV)
NASDAQ: ROIV · Real-Time Price · USD
14.73
-0.21 (-1.44%)
Sep 23, 2025, 4:00 PM EDT - Market closed
Roivant Sciences Market Cap
Roivant Sciences has a market cap or net worth of $10.06 billion as of September 23, 2025. Its market cap has increased by 11.54% in one year.
Market Cap
10.06B
Enterprise Value
5.71B
1-Year Change
11.54%
Ranking
Category
Stock Price
$14.73
Market Cap Chart
Since December 8, 2020, Roivant Sciences's market cap has increased from $533.38M to $10.06B, an increase of 1,785.24%. That is a compound annual growth rate of 84.57%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 22, 2025 | 10.20B | 18.47% |
| Dec 31, 2024 | 8.61B | -4.61% |
| Dec 29, 2023 | 9.03B | 55.76% |
| Dec 30, 2022 | 5.80B | -18.13% |
| Dec 31, 2021 | 7.08B | 1,257.32% |
| Dec 31, 2020 | 521.58M | -2.21% |
| Dec 8, 2020 | 533.38M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 677.75B |
| Johnson & Johnson | 419.56B |
| AbbVie | 393.22B |
| UnitedHealth Group | 309.11B |
| Novo Nordisk | 268.59B |
| AstraZeneca | 240.79B |
| Novartis AG | 239.81B |
| Abbott Laboratories | 237.78B |